Related Diseases
Schizophrenia
Description
PHA-543613 acts as a potent and selective agonist for the α7 subtype of neural nicotinic acetylcholine receptors, with a high level of brain penetration and good oral bioavailability. It is under development as a possible treatment for cognitive deficits in schizophrenia.
Chemical Formula
C15H17N3O2
Elemental Analysis
C, 66.40; H, 6.32; N, 15.49; O, 11.79
Synonym
PHA-543613; PHA 543613; PHA543613.
IUPAC/Chemical Name
(R)-N-(Quinuclidin-3-yl)furo(2,3-C)pyridine-5-carboxamide
InChi Key
IPKZCLGGYKRDES-ZDUSSCGKSA-N
InChi Code
InChI=1S/C15H17N3O2/c19-15(12-7-11-3-6-20-14(11)8-16-12)17-13-9-18-4-1-10(13)2-5-18/h3,6-8,10,13H,1-2,4-5,9H2,(H,17,19)/t13-/m0/s1
SMILES Code
O=C(C1=CC2=C(OC=C2)C=N1)N[C@H]3CN4CCC3CC4
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4℃ for short term (days to weeks), or -20℃ for long term (months).
HS Tariff Code
2934.99.9001